These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 25902746)
21. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys. Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914 [TBL] [Abstract][Full Text] [Related]
22. Predictors of No-show Rate in the GI Endoscopy Suite at a Safety Net Academic Medical Center. Shuja A; Harris C; Aldridge P; Malespin M; de Melo SW J Clin Gastroenterol; 2019 Jan; 53(1):29-33. PubMed ID: 28961577 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness of a short message service intervention to motivate people with positive results in preliminary colorectal cancer screening to undergo colonoscopy: A randomized controlled trial. Wu Y; Liang Y; Zhou Q; Liu H; Lin G; Cai W; Li Y; Gu J Cancer; 2019 Jul; 125(13):2252-2261. PubMed ID: 30825395 [TBL] [Abstract][Full Text] [Related]
25. Trends in colorectal cancer testing among Medicare subpopulations. Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761 [TBL] [Abstract][Full Text] [Related]
26. Implementation of screening colonoscopy amongst first- degree relatives of patients with colorectal cancer in Turkey: a cross-sectional questionnaire based survey. Adakan Y; Taskoparan M; Cekin AH; Duman A; Harmandar F; Taskin V; Yilmaz U; Yesil B Asian Pac J Cancer Prev; 2014; 15(14):5523-8. PubMed ID: 25081658 [TBL] [Abstract][Full Text] [Related]
27. Predicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment tool. Ladabaum U; Patel A; Mannalithara A; Sundaram V; Mitani A; Desai M Cancer; 2016 Sep; 122(17):2663-70. PubMed ID: 27219715 [TBL] [Abstract][Full Text] [Related]
28. Adherence to physician recommendations for surveillance in opportunistic colorectal cancer screening: the necessity of organized surveillance. Stock C; Holleczek B; Hoffmeister M; Stolz T; Stegmaier C; Brenner H PLoS One; 2013; 8(12):e82676. PubMed ID: 24324821 [TBL] [Abstract][Full Text] [Related]
29. Providers role in colonoscopy screening for colorectal cancer. Ramdass P; Petraro P; Via C; Shahrokni A; Nawaz H Am J Health Behav; 2014 Mar; 38(2):234-44. PubMed ID: 24629552 [TBL] [Abstract][Full Text] [Related]
30. Impact of a Clinical Decision Support System on Guideline Adherence of Surveillance Recommendations for Colonoscopy After Polypectomy. Magrath M; Yang E; Ahn C; Mayorga CA; Gopal P; Murphy CC; Gupta S; Agrawal D; Halm EA; Borton EK; Skinner CS; Singal AG J Natl Compr Canc Netw; 2018 Nov; 16(11):1321-1328. PubMed ID: 30442733 [No Abstract] [Full Text] [Related]
31. Adherence to colorectal cancer screening measured as the proportion of time covered. Murphy CC; Sigel BM; Yang E; Skinner CS; Halm EA; Gupta S; Sanders JM; McCallister K; Singal AG Gastrointest Endosc; 2018 Aug; 88(2):323-331.e2. PubMed ID: 29477302 [TBL] [Abstract][Full Text] [Related]
32. Colorectal Cancer Identification Methods Among Kansas Medicare Beneficiaries, 2008-2010. Lai SM; Jungk J; Garimella S Prev Chronic Dis; 2015 Jul; 12():E107. PubMed ID: 26160293 [TBL] [Abstract][Full Text] [Related]
33. Advances in CRC Prevention: Screening and Surveillance. Dekker E; Rex DK Gastroenterology; 2018 May; 154(7):1970-1984. PubMed ID: 29454795 [TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer screening among men and women in the United States. Peterson NB; Murff HJ; Ness RM; Dittus RS J Womens Health (Larchmt); 2007; 16(1):57-65. PubMed ID: 17324097 [TBL] [Abstract][Full Text] [Related]
35. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Brenner H; Chang-Claude J; Jansen L; Knebel P; Stock C; Hoffmeister M Gastroenterology; 2014 Mar; 146(3):709-17. PubMed ID: 24012982 [TBL] [Abstract][Full Text] [Related]
36. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence. Inadomi JM J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898 [TBL] [Abstract][Full Text] [Related]
37. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818 [TBL] [Abstract][Full Text] [Related]
38. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M; Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521 [TBL] [Abstract][Full Text] [Related]
39. Underuse of surveillance colonoscopy in patients at increased risk of colorectal cancer. Murphy CC; Lewis CL; Golin CE; Sandler RS Am J Gastroenterol; 2015 May; 110(5):633-41. PubMed ID: 25384901 [TBL] [Abstract][Full Text] [Related]
40. Colonoscopy is the preferred colorectal cancer screening method in a population-based program. Marbet UA; Bauerfeind P; Brunner J; Dorta G; Valloton JJ; Delcò F Endoscopy; 2008 Aug; 40(8):650-5. PubMed ID: 18609465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]